BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gold JE, Okyay RA, Licht WE, Hurley DJ. Investigation of Long COVID Prevalence and Its Relationship to Epstein-Barr Virus Reactivation. Pathogens 2021;10:763. [PMID: 34204243 DOI: 10.3390/pathogens10060763] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Durmaz A, Yilmaz M. Long-Covid: What Awaits Us After Corona Infection? Journal of Basic and Clinical Health Sciences. [DOI: 10.30621/jbachs.1021549] [Reference Citation Analysis]
2 Gluckman TJ, Bhave NM, Allen LA, Chung EH, Spatz ES, Ammirati E, Baggish AL, Bozkurt B, Cornwell WK, Harmon KG, Kim JH, Lala A, Levine BD, Martinez MW, Onuma O, Phelan D, Puntmann VO, Rajpal S, Taub PR, Verma AK. 2022 ACC Expert Consensus Decision Pathway on Cardiovascular Sequelae of COVID-19 in Adults: Myocarditis and Other Myocardial Involvement, Post-Acute Sequelae of SARS-CoV-2 Infection, and Return to Play. Journal of the American College of Cardiology 2022. [DOI: 10.1016/j.jacc.2022.02.003] [Cited by in Crossref: 26] [Cited by in F6Publishing: 12] [Article Influence: 26.0] [Reference Citation Analysis]
3 Musialik J, Kolonko A, Więcek A. Increased EBV DNAemia after Anti-SARS-CoV-2 Vaccination in Solid Organ Transplants. Vaccines 2022;10:992. [DOI: 10.3390/vaccines10070992] [Reference Citation Analysis]
4 Buonsenso D, Piazza M, Boner AL, Bellanti JA. Long COVID: A proposed hypothesis-driven model of viral persistence for the pathophysiology of the syndrome. Allergy Asthma Proc 2022;43:187-93. [PMID: 35524358 DOI: 10.2500/aap.2022.43.220018] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Piazza M, Di Cicco M, Pecoraro L, Ghezzi M, Peroni D, Comberiati P. Long COVID-19 in Children: From the Pathogenesis to the Biologically Plausible Roots of the Syndrome. Biomolecules 2022;12:556. [DOI: 10.3390/biom12040556] [Reference Citation Analysis]
6 Maple PAC. Multiple Sclerosis, Viruses, and New Vaccines. Neurol Int 2021;13:712-4. [PMID: 34940754 DOI: 10.3390/neurolint13040068] [Reference Citation Analysis]
7 Ahamed J, Laurence J. Long COVID endotheliopathy: hypothesized mechanisms and potential therapeutic approaches. J Clin Invest 2022;132:e161167. [PMID: 35912863 DOI: 10.1172/JCI161167] [Reference Citation Analysis]
8 Barh D, Tiwari S, Gabriel Rodrigues Gomes L, Weener ME, Alzahrani KJ, Alsharif KF, Aljabali AAA, Tambuwala MM, Lundstrom K, Hassan SS, Serrano-Aroca Á, Takayama K, Ghosh P, Redwan EM, Silva Andrade B, Soares SC, Azevedo V, Uversky VN. Potential Molecular Mechanisms of Rare Anti-Tumor Immune Response by SARS-CoV-2 in Isolated Cases of Lymphomas. Viruses 2021;13:1927. [PMID: 34696358 DOI: 10.3390/v13101927] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Stallmach A, Kesselmeier M, Bauer M, Gramlich J, Finke K, Fischer A, Fleischmann-Struzek C, Heutelbeck A, Katzer K, Mutschke S, Pletz MW, Quickert S, Reinhart K, Stallmach Z, Walter M, Scherag A, Reuken PA. Comparison of fatigue, cognitive dysfunction and psychological disorders in post-COVID patients and patients after sepsis: is there a specific constellation? Infection 2022. [PMID: 34997542 DOI: 10.1007/s15010-021-01733-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
10 Graham EL, Koralnik IJ, Liotta EM. Therapeutic Approaches to the Neurologic Manifestations of COVID-19. Neurotherapeutics 2022. [PMID: 35861926 DOI: 10.1007/s13311-022-01267-y] [Reference Citation Analysis]
11 Paganelli R. Resurrecting Epstein–Barr Virus. Pathogens 2022;11:772. [DOI: 10.3390/pathogens11070772] [Reference Citation Analysis]
12 Su Y, Yuan D, Chen DG, Ng RH, Wang K, Choi J, Li S, Hong S, Zhang R, Xie J, Kornilov SA, Scherler K, Pavlovitch-Bedzyk AJ, Dong S, Lausted C, Lee I, Fallen S, Dai CL, Baloni P, Smith B, Duvvuri VR, Anderson KG, Li J, Yang F, Duncombe CJ, McCulloch DJ, Rostomily C, Troisch P, Zhou J, Mackay S, DeGottardi Q, May DH, Taniguchi R, Gittelman RM, Klinger M, Snyder TM, Roper R, Wojciechowska G, Murray K, Edmark R, Evans S, Jones L, Zhou Y, Rowen L, Liu R, Chour W, Algren HA, Berrington WR, Wallick JA, Cochran RA, Micikas ME, Wrin T, Petropoulos CJ, Cole HR, Fischer TD, Wei W, Hoon DSB, Price ND, Subramanian N, Hill JA, Hadlock J, Magis AT, Ribas A, Lanier LL, Boyd SD, Bluestone JA, Chu H, Hood L, Gottardo R, Greenberg PD, Davis MM, Goldman JD, Heath JR; ISB-Swedish COVID-19 Biobanking Unit. Multiple early factors anticipate post-acute COVID-19 sequelae. Cell 2022;185:881-895.e20. [PMID: 35216672 DOI: 10.1016/j.cell.2022.01.014] [Cited by in Crossref: 45] [Cited by in F6Publishing: 17] [Article Influence: 45.0] [Reference Citation Analysis]
13 Chantre-justino M, Figueiredo MC, Alves G, Ornellas MHF. Prevalence of Epstein–Barr virus infection in recurrent respiratory papillomatosis and the influence on disease severity. Diagnostic Microbiology and Infectious Disease 2022. [DOI: 10.1016/j.diagmicrobio.2022.115655] [Reference Citation Analysis]
14 Williams JE, Moramarco J. The Role of Acupuncture for Long COVID: Mechanisms and Models. Medical Acupuncture 2022;34:159-66. [DOI: 10.1089/acu.2021.0090] [Reference Citation Analysis]
15 Carneiro VCDS, Alves-leon SV, Sarmento DJDS, Coelho WLDCNP, Moreira ODC, Salvio AL, Ramos CHF, Ramos Filho CHF, Marques CAB, da Costa Gonçalves JP, Leon LAA, de Paula VS. Herpesvirus and neurological manifestations in patients with severe coronavirus disease. Virol J 2022;19. [DOI: 10.1186/s12985-022-01828-9] [Reference Citation Analysis]
16 Hamdy A, Leonardi A. Superantigens and SARS-CoV-2. Pathogens 2022;11:390. [DOI: 10.3390/pathogens11040390] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Barrea L, Verde L, Grant WB, Frias-toral E, Sarno G, Vetrani C, Ceriani F, Garcia-velasquez E, Contreras-briceño J, Savastano S, Colao A, Muscogiuri G. Vitamin D: A Role Also in Long COVID-19? Nutrients 2022;14:1625. [DOI: 10.3390/nu14081625] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
18 Hashimoto Y, Suzuki T, Hashimoto K. Comments to "Fluvoxamine and long COVID-19: a new role for sigma-1 receptor (S1R) agonists" by Khani and Entezari-Maleki. Mol Psychiatry 2022. [PMID: 35388183 DOI: 10.1038/s41380-022-01546-2] [Reference Citation Analysis]
19 Papasavvas I, de Courten C, Herbort CP Jr. Varicella-zoster virus reactivation causing herpes zoster ophthalmicus (HZO) after SARS-CoV-2 vaccination - report of three cases. J Ophthalmic Inflamm Infect 2021;11:28. [PMID: 34529153 DOI: 10.1186/s12348-021-00260-4] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
20 Morrow AK, Malone LA, Kokorelis C, Petracek LS, Eastin EF, Lobner KL, Neuendorff L, Rowe PC. Long-Term COVID 19 Sequelae in Adolescents: the Overlap with Orthostatic Intolerance and ME/CFS. Curr Pediatr Rep. [DOI: 10.1007/s40124-022-00261-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
21 Ruiz-Pablos M. CD4+ Cytotoxic T Cells Involved in the Development of EBV-Associated Diseases. Pathogens 2022;11:831. [PMID: 35894054 DOI: 10.3390/pathogens11080831] [Reference Citation Analysis]
22 Ortona E, Malorni W. Long COVID: to investigate immunological mechanisms and sex/gender related aspects as fundamental steps for a tailored therapy. Eur Respir J 2021:2102245. [PMID: 34531277 DOI: 10.1183/13993003.02245-2021] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
23 Kawaura R, Utakata R, Kondo D, Wakaoka T, Ohnishi M. A Case Found to Be Severe Acute Respiratory Syndrome Coronavirus 2 Positive Immediately Before Hospitalization for Infectious Mononucleosis. Cureus 2021;13:e19344. [PMID: 34909305 DOI: 10.7759/cureus.19344] [Reference Citation Analysis]
24 Horowitz RI, Freeman PR. Efficacy of Short-Term High Dose Pulsed Dapsone Combination Therapy in the Treatment of Chronic Lyme Disease/Post-Treatment Lyme Disease Syndrome (PTLDS) and Associated Co-Infections: A Report of Three Cases and Literature Review. Antibiotics 2022;11:912. [DOI: 10.3390/antibiotics11070912] [Reference Citation Analysis]
25 Guaraldi G, Milic J, Cesari M, Leibovici L, Mandreoli F, Missier P, Rozzini R, Cattelan AM, Motta F, Mussini C, Cossarizza A. The interplay of post-acute COVID-19 syndrome and aging: a biological, clinical and public health approach. Ageing Res Rev 2022;:101686. [PMID: 35820609 DOI: 10.1016/j.arr.2022.101686] [Reference Citation Analysis]
26 Blumenthal MJ, Lambarey H, Chetram A, Riou C, Wilkinson RJ, Schäfer G. Kaposi's Sarcoma-Associated Herpesvirus, but Not Epstein-Barr Virus, Co-infection Associates With Coronavirus Disease 2019 Severity and Outcome in South African Patients. Front Microbiol 2021;12:795555. [PMID: 35069495 DOI: 10.3389/fmicb.2021.795555] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
27 Khani E, Entezari-Maleki T. Fluvoxamine and long COVID-19; a new role for sigma-1 receptor (S1R) agonists. Mol Psychiatry 2022. [PMID: 35388182 DOI: 10.1038/s41380-022-01545-3] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Buonsenso D, Valentini P, De Rose C, Tredicine M, Pereyra Boza MDC, Camponeschi C, Morello R, Zampino G, Brooks AES, Rende M, Ria F, Sanguinetti M, Delogu G, Sali M, Di Sante G; on behalf of the Gemelli-Pediatric COVID-19 Team. Recovering or Persisting: The Immunopathological Features of SARS-CoV-2 Infection in Children. JCM 2022;11:4363. [DOI: 10.3390/jcm11154363] [Reference Citation Analysis]
29 Simões RSQ, Rodríguez-Lázaro D. Classical and Next-Generation Vaccine Platforms to SARS-CoV-2: Biotechnological Strategies and Genomic Variants. Int J Environ Res Public Health 2022;19:2392. [PMID: 35206580 DOI: 10.3390/ijerph19042392] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Nunn AVW, Guy GW, Botchway SW, Bell JD. SARS-CoV-2 and EBV; the cost of a second mitochondrial "whammy"? Immun Ageing 2021;18:40. [PMID: 34717676 DOI: 10.1186/s12979-021-00252-x] [Reference Citation Analysis]
31 Gamain B, Brousse C, Rainey NE, Diallo BK, Paquereau CE, Desrames A, Ceputyte J, Semblat JP, Bertrand O, Gangnard S, Teillaud JL, Chêne A. BMFPs, a versatile therapeutic tool for redirecting a preexisting Epstein-Barr virus antibody response toward defined target cells. Sci Adv 2022;8:eabl4363. [PMID: 35148183 DOI: 10.1126/sciadv.abl4363] [Reference Citation Analysis]
32 Sausen DG, Bhutta MS, Gallo ES, Dahari H, Borenstein R. Stress-Induced Epstein-Barr Virus Reactivation. Biomolecules 2021;11:1380. [PMID: 34572593 DOI: 10.3390/biom11091380] [Reference Citation Analysis]
33 Nunhofer V, Weidner L, Hoeggerl AD, Zimmermann G, Badstuber N, Grabmer C, Jungbauer C, Lindlbauer N, Held N, Pascariuc M, Ortner T, Rohde E, Laner-plamberger S. Persistence of Naturally Acquired and Functional SARS-CoV-2 Antibodies in Blood Donors One Year after Infection. Viruses 2022;14:637. [DOI: 10.3390/v14030637] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 Sun Z, Wu T, Xie H, Li Y, Zhang J, Su X, Qi H. The Role of Cellular Immunity in the Protective Efficacy of the SARS-CoV-2 Vaccines. Vaccines (Basel) 2022;10:1103. [PMID: 35891267 DOI: 10.3390/vaccines10071103] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Fülöp Á, Torma G, Moldován N, Szenthe K, Bánáti F, Almsarrhad IAA, Csabai Z, Tombácz D, Minárovits J, Boldogkői Z. Integrative profiling of Epstein-Barr virus transcriptome using a multiplatform approach. Virol J 2022;19:7. [PMID: 34991630 DOI: 10.1186/s12985-021-01734-6] [Cited by in F6Publishing: 1] [Reference Citation Analysis]